News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
David Matthew T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/18/2023 |
4
| David Matthew T (CFO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 125,000 options to buy
@ $4.43, valued at
$553.8k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| David Matthew T (Interim CEO and CFO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 1,000 shares
@ $5.07, valued at
$5.1k
|
|
| 11/10/2021 |
4
| David Matthew T (Interim CEO and CFO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 125,000 options to buy
@ $5.56, valued at
$695k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2020 |
4
| David Matthew T (CFO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 1,150 shares
@ $4.07, valued at
$4.7k
|
|
| 05/13/2020 |
4
| David Matthew T (EVP, CFO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 125,000 options to buy
@ $5.63, valued at
$703.8k
Granted 125,000 options to buy
@ $4.08, valued at
$510k
|
|
|
|